Cargando…

NGR‐hTNF and Doxorubicin as Second‐Line Treatment of Patients with Small Cell Lung Cancer

LESSONS LEARNED. NGR‐hTNF was safely combined with doxorubicin, showing a promising antitumor activity in unselected patients with relapsed small cell lung cancer. Similar antitumor activity was observed in platinum‐sensitive and platinum‐resistant patient cohorts. BACKGROUND. Relapsed small cell lu...

Descripción completa

Detalles Bibliográficos
Autores principales: Gregorc, Vanesa, Cavina, Raffaele, Novello, Sivia, Grossi, Francesco, Lazzari, Chiara, Capelletto, Enrica, Genova, Carlo, Salini, Giulia, Lambiase, Antonio, Santoro, Armando
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AlphaMed Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6263121/
https://www.ncbi.nlm.nih.gov/pubmed/30076277
http://dx.doi.org/10.1634/theoncologist.2018-0292